BioSpace News Archive

The global cell transfection market is expected to expand at a remarkable CAGR during the forecast period from 2023 to 2032.

Genetic metabolic diseases are conditions that disrupt an individual’s metabolism, which is the chemical process responsible for converting food into energy and eliminating toxins from the body.

QuBind, a startup at the forefront of T-cell therapy innovation, announces a significant development in immunotherapy with its AI-integrated platform.

SPR Therapeutics, Inc. announced the final patient was enrolled in the RESET Clinical Trial of SPRINT® PNS for the treatment of chronic low back pain.

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, announced that it will host a virtual KOL (Key Opinion Leader) event on data presented during the 2023 ASH annual meeting including efficacy and safety results for its lead drug candidate, MaaT013.

Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the completion of an oversubscribed $165 million Series C financing.

BioNTech SE will inaugurate its first African site in Kigali, Rwanda, on Monday, December 18th, 2023.

Neumora Therapeutics, Inc. today announced the appointment of Jason Duncan as chief legal officer.

Suzhou OSAI Biopharma, Inc., a biopharmaceutical company focused on developing live biotherapeutic products (LBPs), today announced that its Phase III clinical trial of vaginal L. crispatus live bacteria capsule (Lc262-1) has successfully met its primary and secondary endpoints.

ChemDiv Inc., dedicated to partnering in discovery and development of breakthrough therapies based on its unique chem-bio platforms, announces the presentation of non-clinical summary data for the best-in-class selective FLT3 clinical candidate at the 65th ASH Annual Meeting and Exposition in San Diego, CA.